New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis

Kadri Altundag

doi:10.1016/j.clbc.2016.11.010

New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis

Kadri Altundag

Professor of Medical Oncology

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e163
Journal	Clinical Breast Cancer
Volume	17
Issue number	3
DOIs	https://doi.org/10.1016/j.clbc.2016.11.010
Publication status	Published - Jun 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.clbc.2016.11.010

Cite this

@article{71c0cabd8358424bb22b63cd12513e2d,

title = "New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis",

author = "Kadri Altundag",

year = "2017",

month = jun,

doi = "10.1016/j.clbc.2016.11.010",

language = "English",

volume = "17",

pages = "e163",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis

AU - Altundag, Kadri

PY - 2017/6

Y1 - 2017/6

UR - https://www.scopus.com/pages/publications/85011103426

U2 - 10.1016/j.clbc.2016.11.010

DO - 10.1016/j.clbc.2016.11.010

M3 - Letter

C2 - 28161133

AN - SCOPUS:85011103426

SN - 1526-8209

VL - 17

SP - e163

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

IS - 3

ER -

New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis

UN SDGs

Access to Document

Other files and links

Cite this